Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial

BACKGROUND: Glaucoma is the leading cause of irreversible blindness in the world. Estimated to affect 60 million people worldwide, this figure is expected to rise to 80 million by 2020. Untreated, glaucoma leads to visual decay and eventually to blindness, and can significantly reduce quality of lif...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Trials
Autores principales: Lamoureux, Ecosse L., Mcintosh, Rachel, Constantinou, Marios, Fenwick, Eva K., Xie, Jing, Casson, Robert, Finkelstein, Eric, Goldberg, Ivan, Healey, Paul, Thomas, Ravi, Ang, Ghee Soon, Pesudovs, Konrad, Crowston, Jonathan
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4567808/
https://ncbi.nlm.nih.gov/pubmed/26362541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0924-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares